Clinical Trial Update: Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a pentostatin-alemtuzumab preparative regimen for allogeneic peripheral blood stem cell transplantation; the study was terminated and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Lymphoma
• Multiple Myeloma
• Renal Cell Carcinoma

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Pentostatin (pentostatin)

Snippet

Sponsor: University of Arizona | Conditions: Leukemia, Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2011-01-12